Akari Therapeutics Insider Trades
NASDAQ: AKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Akari Therapeutics insider activity
Over the last 12 months, Akari Therapeutics insiders reported 16 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Gaslightwala Abizer (CEO) reporting a transaction in 6,430 shares at $9.72 on Sep 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AKTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AKTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 29, 2026 | Gaslightwala AbizerCEO | Award | 6,430 | $62.50K | Form 4 |
| Aug 17, 2026 | Farag Kameel D.Interim CFO | Award | 1,728 | $12.99K | Form 4 |
| Jul 16, 2026 | Farag Kameel D.Interim CFO | Award | 1,130 | $12.99K | Form 4 |
| Jul 7, 2026 | Patel Samir RashmikantDirector | Option exercise | 5,799 | $2.32 | Form 4 |
| Jul 7, 2026 | Patel Samir RashmikantDirector | Option exercise | 15,466 | $6.19 | Form 4 |
| Jul 7, 2026 | Patel Samir RashmikantDirector | Option exercise | 1,209 | $9.67K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 1,000 | $13.00K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 7,353 | $27.50K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 3,725 | $13.00K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 2,539 | $13.00K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 1,570 | $13.00K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 1,395 | $13.00K | Form 4 |
| Jun 24, 2026 | Farag Kameel D.Interim CFO | Award | 1,248 | $12.50K | Form 4 |
| Nov 1, 2025 | Farag Kameel D.Interim CFO | Award | 26,619 | $19.96K | Form 4 |
| Nov 1, 2025 | Farag Kameel D.Interim CFO | Award | 32,000 | $24.00K | Form 4 |
| Oct 22, 2025 | Farag Kameel D.Interim CFO | Award | 6,277 | $4.64K | Form 4 |
| Aug 25, 2025 | Gaslightwala AbizerCEO | Buy | 3,000 | $2.70K | Form 4 |
| Aug 22, 2025 | Gaslightwala AbizerCEO | Buy | 8,000 | $7.44K | Form 4 |
| Aug 21, 2025 | Gaslightwala AbizerCEO | Buy | 10,000 | $9.40K | Form 4 |
| Jun 24, 2025 | Gaslightwala AbizerPresident & CEO | Buy | 5,203 | $6.04K | Form 4 |
| Jun 23, 2025 | Gaslightwala AbizerPresident & CEO | Buy | 943 | $1.08K | Form 4 |
| Jun 20, 2025 | Gaslightwala AbizerPresident & CEO | Buy | 10,000 | $12.00K | Form 4 |
| Jun 17, 2025 | Gaslightwala AbizerPresident & CEO | Buy | 15,000 | $18.00K | Form 4 |
| Jun 13, 2025 | Gaslightwala AbizerCEO | Award | 25,000 | $29.75K | Form 4 |
| Jun 12, 2025 | Gaslightwala AbizerCEO | Award | 20,000 | $24.60K | Form 4 |
| Jun 10, 2025 | Gaslightwala AbizerCEO | Award | 20,000 | $25.40K | Form 4 |
| Mar 6, 2025 | Bazemore Robert BDirector | Award | 44,642 | $50.00K | Form 4 |
| Mar 6, 2025 | Gaslightwala AbizerDirector | Award | 133,928 | $150.00K | Form 4 |
| Mar 6, 2025 | Neal James RDirector | Award | 4,464 | $5.00K | Form 4 |
| Mar 6, 2025 | Patel Samir RashmikantDirector | Award | 406,250 | $455.00K | Form 4 |
| Mar 6, 2025 | Huh HoyoungDirector | Award | 892,857 | $1000.00K | Form 4 |
| Mar 6, 2025 | Prudo-Chlebosz RaymondDirector | Award | 446,428 | $500.00K | Form 4 |
| Mar 6, 2025 | Patel Sandip IDirector | Award | 44,642 | $50.00K | Form 4 |
| Jan 10, 2025 | Hombeck TorstenCFO | Award | 200 | $244 | Form 4 |
| Jan 10, 2025 | Gaslightwala AbizerDirector | Award | 11,439 | $13.96K | Form 4 |
| Jan 10, 2025 | Gaslightwala AbizerDirector | Award | 11,640 | $14.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4